Treating hypertension in type 2 diabetes

被引:9
作者
Grossman, Yoni [1 ,2 ,4 ]
Shlomai, Gadi [1 ,2 ,3 ,4 ]
Grossman, Ehud [1 ,2 ,4 ]
机构
[1] Chaim Sheba Med Ctr, Dept Internal Med D, IL-52621 Tel Hashomer, Israel
[2] Hypertens Unit, Tel Hashomer, Israel
[3] Dr Pinchas Borenstein Talpiot Med Leadership Prog, IL-52621 Tel Hashomer, Israel
[4] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
blood pressure; diabetes mellitus; target; treatment; CONVERTING ENZYME-INHIBITORS; SYSTOLIC BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; ANTIHYPERTENSIVE TREATMENT; CALCIUM-ANTAGONISTS; RECEPTOR BLOCKER; LOWERING ARM; HIGH-RISK; MELLITUS; OUTCOMES;
D O I
10.1517/14656566.2014.947267
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: The co-existence of hypertension and diabetes mellitus is very common. Hypertension remarkably increases the cardiovascular risk in diabetic patients. Lowering blood pressure (BP) in these patients is particularly beneficial. Areas covered: This paper will discuss what the target BP is for diabetic patients and how that target can be reached. Expert opinion: Previous guidelines recommended lowering BP < 130/80 mmHg in diabetic patients. However, recent studies did not support this target and accordingly most recent guidelines recommend lowering BP to < 140/90 mmHg in diabetic patients. Non-pharmacological approaches are recommended in all patients. If BP levels are above the target despite non-pharmacological treatment, drug therapy should be initiated. Despite the lack of clear evidence, blockers of the renin-angiotensin-aldosterone system (RAAS) represent the cornerstone of the antihypertensive arsenal; however, in most patients combination therapy is required. Combination of RAAS blocker and a calcium antagonist is the preferred one. In many patients three or four drugs are needed. Treatment should be individualized according to concomitant risk factors and diseases and according hemodynamic and laboratory parameters as well as age. In order to maximally reduce cardiorenal risk, lipid and glycemic control should also be achieved.
引用
收藏
页码:2131 / 2140
页数:10
相关论文
共 68 条
[1]   Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study [J].
Adler, AI ;
Stratton, IM ;
Neil, HAW ;
Yudkin, JS ;
Matthews, DR ;
Cull, CA ;
Wright, AD ;
Turner, RC ;
Holman, RR .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258) :412-419
[2]  
Amer Diabet Assoc, 2002, DIABETES CARE, V25, P213
[3]  
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]
[4]  
American Diabetes Association, 2010, DIABETES CARE, V33, pS11, DOI DOI 10.2337/dc10-S011
[5]  
[Anonymous], 1991, JAMA, V265, P3255
[6]   Global Guideline for Type 2 Diabetes [J].
不详 .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 104 (01) :1-52
[7]  
[Anonymous], 2011, BMJ, V343, pd4891, DOI DOI 10.1136/BMJ.D4891
[8]  
[Anonymous], 2000, Lancet, V355, P253, DOI [10.1016/S0140-6736(99)12323-7, DOI 10.1016/S0140-6736(99)12323-7]
[9]   THE PROSPECTIVE CARDIOVASCULAR MUNSTER (PROCAM) STUDY - PREVALENCE OF HYPERLIPIDEMIA IN PERSONS WITH HYPERTENSION AND OR DIABETES-MELLITUS AND THE RELATIONSHIP TO CORONARY HEART-DISEASE [J].
ASSMANN, G ;
SCHULTE, H .
AMERICAN HEART JOURNAL, 1988, 116 (06) :1713-1724
[10]   Meta-analysis of 94,492 patients with hypertension treated with beta Blockers to determine the risk of new-onset diabetes Mellitus [J].
Bangalore, Sripal ;
Parkar, Sanobar ;
Grossman, Ehud ;
Messerli, Franz H. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (08) :1254-1262